These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7906070)

  • 1. Expression of the c-erbB-2-encoded oncoprotein and progesterone receptor in human meningiomas.
    Schlegel J; Ullrich B; Stumm G; Gass P; Harwerth IM; Hynes NE; Kiessling M
    Acta Neuropathol; 1993; 86(5):473-9. PubMed ID: 7906070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas.
    Chozick BS; Benzil DL; Stopa EG; Pezzullo JC; Knuckey NW; Epstein MH; Finkelstein SD; Finch PW
    J Neurooncol; 1996 Feb; 27(2):117-26. PubMed ID: 8699233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of neu/c-erbB-2 in human brain tumors.
    Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H
    Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma.
    Kuratsu JI; Seto H; Kochi M; Ushio Y
    Acta Neurochir (Wien); 1994; 131(3-4):289-93. PubMed ID: 7754837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor expression in meningiomas.
    Carroll RS; Glowacka D; Dashner K; Black PM
    Cancer Res; 1993 Mar; 53(6):1312-6. PubMed ID: 8443810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group.
    Nathan B; Gusterson B; Jadayel D; O'Hare M; Anbazhagan R; Jayatilake H; Ebbs S; Micklem K; Price K; Gelber R
    Ann Oncol; 1994 May; 5(5):409-14. PubMed ID: 7915536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells.
    Leães CG; Meurer RT; Coutinho LB; Ferreira NP; Pereira-Lima JF; da Costa Oliveira M
    Neuropathology; 2010 Feb; 30(1):44-9. PubMed ID: 19703265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
    Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
    Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone receptor, bc1-2 and bax expression in meningiomas.
    Verheijen FM; Donker GH; Viera CS; Sprong M; Jacobs HM; Blaauw G; Thijssen JH; Blankenstein MA
    J Neurooncol; 2002 Jan; 56(1):35-41. PubMed ID: 11949825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas.
    Khalid H
    Cancer; 1994 Jul; 74(2):679-85. PubMed ID: 8033047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor isoform expression in human meningiomas.
    Verheijen FM; Sprong M; Jacobs HM; Donker GH; Amelink GJ; Thijssen JH; Blankenstein MA
    Eur J Cancer; 2001 Aug; 37(12):1488-95. PubMed ID: 11506955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-erbB-2/HER-2 protein in human intracranial tumours.
    Torp SH; Helseth E; Unsgaard G; Dalen A
    Eur J Cancer; 1993; 29A(11):1604-6. PubMed ID: 8105841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of progesterone receptor status in meningiomas.
    Roser F; Nakamura M; Bellinzona M; Rosahl SK; Ostertag H; Samii M
    J Clin Pathol; 2004 Oct; 57(10):1033-7. PubMed ID: 15452155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
    Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
    Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
    Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
    Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of disregulated c-myc but not c-sis/PDGF in atypical and anaplastic meningiomas.
    Nagashima G; Aoyagi M; Yamamoto S; Wakimoto H; Tamaki M; Yamamoto K; Fujimoto T; Hirakawa K
    Clin Neurol Neurosurg; 2001 Apr; 103(1):13-8. PubMed ID: 11311470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary study on oncogene product immunohistochemistry (c-erbB-2, c-myc, ras p21, EGFR) in breast pathology.
    Saccani Jotti G; Fontanesi M; Bombardieri E; Gabrielli M; Veronesi P; Bianchi M; Becchi G; Bogni A; Tardini A
    Int J Biol Markers; 1992; 7(1):35-42. PubMed ID: 1349907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidermal growth factor receptor is associated with phospholipase C-gamma 1 in meningiomas.
    Johnson MD; Horiba M; Winnier AR; Arteaga CL
    Hum Pathol; 1994 Feb; 25(2):146-53. PubMed ID: 8119714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
    Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
    J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature.
    Strojan P; Popović M; Jereb B
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):65-73. PubMed ID: 10924973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.